Tempus AI (NASDAQ:TEM) Shares Down 3.6% on Insider Selling

Tempus AI, Inc. (NASDAQ:TEM)’s share price fell 3.6% during trading on Thursday following insider selling activity. The company traded as low as $36.72 and last traded at $37.49. 2,982,685 shares traded hands during mid-day trading, a decline of 21% from the average session volume of 3,784,073 shares. The stock had previously closed at $38.88.

Specifically, COO Ryan Fukushima sold 20,000 shares of the business’s stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $39.61, for a total transaction of $792,200.00. Following the sale, the chief operating officer now owns 982,442 shares in the company, valued at approximately $38,914,527.62. The trade was a 2.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on TEM. Loop Capital boosted their price target on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and lifted their price target for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Guggenheim started coverage on shares of Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price objective on the stock. Wolfe Research initiated coverage on shares of Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 price objective for the company. Finally, Piper Sandler reiterated a “neutral” rating and issued a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $56.00.

Tempus AI Stock Up 0.1 %

The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The business’s 50-day simple moving average is $48.45 and its 200 day simple moving average is $46.89.

Institutional Trading of Tempus AI

Several large investors have recently modified their holdings of TEM. Silverleafe Capital Partners LLC bought a new stake in Tempus AI during the fourth quarter valued at approximately $533,000. Franklin Resources Inc. boosted its stake in shares of Tempus AI by 1.0% during the 3rd quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock worth $45,920,000 after acquiring an additional 8,387 shares during the last quarter. Tidal Investments LLC bought a new stake in shares of Tempus AI during the 3rd quarter valued at $7,633,000. Teachers Retirement System of The State of Kentucky increased its stake in shares of Tempus AI by 6.3% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 126,500 shares of the company’s stock worth $7,160,000 after purchasing an additional 7,500 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in Tempus AI by 0.4% in the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock worth $7,537,000 after purchasing an additional 539 shares during the period. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.